Editors:
- Describes the main mechanisms that govern tumor cell resistance to apoptotic stimuli
- Demonstrates the identification of existing agents or the development of new agents that can serve as sensitizing agents with other cytotoxics
- Features the latest research on the results of combining targeted sensitizing agents and conventional cytotoxic therapies
Part of the book series: Resistance to Targeted Anti-Cancer Therapeutics (RTACT, volume 1)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (13 chapters)
-
Front Matter
-
Back Matter
About this book
Editors and Affiliations
-
Dept. Microbiology, Immunology &, Molecular Genetics, University of California, Los Angeles, Los Angeles, USA
Benjamin Bonavida
About the editor
Bibliographic Information
Book Title: Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy
Book Subtitle: Targeted Therapies to Reverse Resistance
Editors: Benjamin Bonavida
Series Title: Resistance to Targeted Anti-Cancer Therapeutics
DOI: https://doi.org/10.1007/978-1-4614-7070-0
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media New York 2013
Hardcover ISBN: 978-1-4614-7069-4
Softcover ISBN: 978-1-4899-8841-6
eBook ISBN: 978-1-4614-7070-0
Series ISSN: 2196-5501
Series E-ISSN: 2196-551X
Edition Number: 1
Number of Pages: XIII, 260
Topics: Cancer Research, Apoptosis, Cell Biology, Drug Resistance